Hints and tips:
Related Special Reports
...Legal scholars have debated whether releases have become too common as companies or organisations facing a pile of “tort” lawsuits over defective products or corporate malfeasance file for bankruptcy in...
...Janssen is the pharmaceutical division of J&J....
...McKee was a senior executive at Janssen Pharmaceuticals, a division of Johnson & Johnson....
...McKinsey said its work with the FDA focused on administrative and operational issues, not advice on regulatory decisions or specific pharmaceutical products such as opioids....
...Lake Nona Fund / LN Sports & Health Tech Fund I, LP . . . Exponent Founders Capital I, LP . . . SH Fund, LP . . . Curated [chef recommends] . . . Race Capital II, LP . . ....
...Vaccines Europe represents drugmakers including AstraZeneca, GlaxoSmithKline, Janssen (which belongs to Johnson & Johnson), Merck, Novavax, Pfizer, Sanofi, Takeda, Abbott and CureVac....
...as a major shareholder of Valeant Pharmaceuticals....
...Settlements either in product liability cases or where private equity firms faced allegations of asset-stripping have often been reached where money contributed to creditor recoveries was exchanged for the...
...“The Janssen vaccine will be another weapon in our arsenal to beat this pandemic,” said vaccines minister Nadhim Zahawi....
...Its biggest product by far was OxyContin, which instead of morphine contained oxycodone, a more potent opioid....
...She said: “We do not believe there will be the need to start at square one with any of these products — we recognise we are in a pandemic and we need to arm healthcare providers with the most appropriate...
...The deal will give J&J’s drugmaking division Janssen Pharmaceutica access to Momenta’s pipeline of products, including nipocalimab, a promising treatment for the rare muscular disease myasthenia gravis that...
...The Pfizer/BioNTech product also uses a new technology, called messenger RNA, long touted as a game-changer....
...The Japanese pharmaceuticals group is still weighed down by the resulting debt. It now plans to sell its non-prescription drugs business to Blackstone for around ¥250bn. It will need to do more....
...Through its Janssen subsidiary, the New Jersey-based drugmaker will administer its experimental vaccine to 6,000 UK volunteers in two doses in a phase 3 trial....
...Doses of the AstraZeneca vaccine will be supplemented by up to 10m doses of the Pfizer/BioNTech vaccine this year, as well as many more doses of the Janssen and Novavax vaccines in the first half of 2021...
..., J&J’s pharmaceutical division....
...Blackstone faced competition for TCHC from other PE companies and the Japanese pharmaceutical group Taisho, but global travel bans left a number of potential trade buyers in Europe and the US unable to send...
...He joined Janssen, J&J’s pharma division, in sales in 1988, with only a BA in biology....
...Narasimhan has committed to spending £2bn to boost growth at RB, which also makes products ranging from Durex condoms to Cillit Bang cleaning spray, but the clean-up could take a while....
...Kerrie Mitchener-Nissen has moved to the Asset Management Exchange (AMX) as head of product for the fund services provider which is owned by Willis Towers Watson, the investment consultant....
...J&J — best known for consumer products such as “no more tears” baby shampoo — owns the Janssen pharmaceuticals business that sold two prescription opioids....
...were neglecting patients in pain — and convincing them their products were not addictive....
...The suit also names as defendants Janssen Pharmaceuticals, a division of Johnson & Johnson, the parent company itself, Mallinckrodt, Endo Health Solutions and Allergan Finance....
...Discovering new drugs is getting harder, added Jennifer Taubert, executive vice-president at Janssen Pharmaceuticals, the drugmaking division of J&J. “The easy diseases have largely been solved....
International Edition